Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

LEXX

Lexaria Bioscience Corp.

CIK 0001348362 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$0.61
↑ 0.01 (1.65%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals, Technicals; Excluded: Options (no data)

Key stats

Market Cap
$15.24M
P/E Ratio
-1.60
EPS
Not covered
Dividend Yield
Not covered
52W Position
14%
Beta
0.94

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
2.45
P/S
41.42
EV/Revenue
27.57
ROE
-153.5%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 14%
$0.46$1.55

Latest Financials

2025-08-31 FY
Revenue
$705.92K
Net Income
-$11.90M
Total Assets
$4.18M
Free Cash Flow
-$10.48M

Recent news